Acorda Therapeutics 8-K Filing Shows Company WIll Oppose Requests To Institute For IPRS, Will Oppose Full Proceedings And Defend Patents

Loading...
Loading...
"On September 2, 2015, and September 3, 2015, a hedge fund (acting with affiliated entities and individuals and proceeding under the name of the Coalition for Affordable Drugs) filed four separate inter partes review (IPR) petitions with the U.S. Patent and Trademark Office, challenging U.S. Patent Nos. 8,007,826, 8,663,685, 8,354,437, and 8,440,703, which are four of the five Ampyra Orange Book-listed patents. Acorda Therapeutics, Inc. (the "Company") will oppose the requests to institute these four IPRs, and if they are allowed to proceed, the Company will oppose the full proceedings and defend its patents"
Posted In: News
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...